AVB
67
2
ISRG
71
5
HST
57
5
SE
68
3
SBUX
44
3
IRM
68
-3
CSCO
51
4
EIX
66
-3
WM
65
3
KIM
57
6
CHRW
50
2
UA
24
-9
INTU
65
5
MDLZ
67
-4
EXC
47
-3
BK
74
2
CME
46
-10
CVX
40
2
GT
50
4
RF
53
3
AVB
67
2
ISRG
71
5
HST
57
5
SE
68
3
SBUX
44
3
IRM
68
-3
CSCO
51
4
EIX
66
-3
WM
65
3
KIM
57
6
CHRW
50
2
UA
24
-9
INTU
65
5
MDLZ
67
-4
EXC
47
-3
BK
74
2
CME
46
-10
CVX
40
2
GT
50
4
RF
53
3
Financhill
Back

Accuray Vs. Perspective Therapeutics Industry Stock Comparison

Buy
59

ARAY
Accuray

Last Price:
1.84
Seasonality Move:
4.79%
Sell
31

CATX
Perspective Therapeutics

Last Price:
13.57
Seasonality Move:
-10.19%
Buy
59
Accuray (ARAY) is a Buy

Is Accuray a Buy, Sell or Hold?

  • The current Accuray [ARAY] share price is $1.89. The Score for ARAY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ARAY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.47. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARAY Stock Price Chart

What is Accuray's stock price today?

  • The Accuray share price today is $1.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARAY is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

ARAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 44.31 Sell
Chaikin Money Flow: -435052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.98 - 2.3) Sell
Bollinger Bands (100): (1.6 - 2.08) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: -538312 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.95 - 15.75) Sell
Bollinger Bands (100): (11.53 - 15.95) Sell

ARAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.02 Sell
20-day SMA: 2.1 Sell
50-day SMA: 1.95 Sell
200-day SMA: 2.23 Sell
8-day EMA: 1.99 Sell
20-day EMA: 2.02 Sell
50-day EMA: 1.97 Sell
200-day EMA: 2.18 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.46 Sell
20-day SMA: 14.98 Sell
50-day SMA: 13.73 Sell
200-day SMA: 11.27 Buy
8-day EMA: 14.11 Sell
20-day EMA: 14.44 Sell
50-day EMA: 13.95 Sell
200-day EMA: 11.5 Buy

Accuray Earnings Growth & ARAY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.15 per share, and an increase next year of $0.14 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Accuray Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):